MAPK3 and cystic fibrosis: Previous work has shown that ERK1/2 and p38 inhibitors can block the inflammatory response of human bronchial epithelial cells infected by germinating A. fumigatus conidia [9], but to the best of our knowledge, this is the first time that MAPK inhibitors have been shown to produce an overall protective response in cells treated with fungal CF.